Literature DB >> 10510059

Dose-response effects of 32P radioactive stents in an atherosclerotic porcine coronary model.

A J Carter1, D Scott, L Bailey, T Hoopes, R Jones, R Virmani.   

Abstract

BACKGROUND: Experimental studies have demonstrated that 32P radioactive stents reduce neointimal formation at 28 days in porcine iliac and coronary arteries. Our objective was to determine the long-term dose-response effects of 1.0- to 12.0-microCi 32P radioactive stents in a porcine atherosclerotic coronary model. METHODS AND
RESULTS: Control (n=19) and 1.0- to 12.0-microCi 32P radioactive (n=43) stents (total, n=62) were implanted in the coronary arteries of 31 miniature swine at 28 days after creation of a fibrocellular plaque by overstretch balloon injury and cholesterol feeding. Angiography and histomorphometry were performed at 6 months. Stent thrombosis occurred in 3 radioactive (7.7%) and no control stents (P=0.54). On histology, the mean neointimal area and the percent in-stent stenosis correlated positively with increasing stent activity (r=0.64, P<0.001). The mean neointimal area (mm2) for the stents with >/=3.0 microCi 32P (3.57+/-1.21) was significantly greater than that for the nonradioactive stents (1.78+/-0.68, P<0.0001). The neointima of the stents with >/=3.0 microCi 32P was composed of smooth muscle cells, matrix proteoglycans, calcification, foam cells, and cholesterol clefts.
CONCLUSIONS: Continuous low-dose-rate irradiation delivered by high-activity (32)P radioactive stents promotes the formation of an "atheromatous" neointima after 6 months in this experimental model. These data may be useful for predicting late tissue responses to radioactive stents in human coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510059     DOI: 10.1161/01.cir.100.14.1548

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2 in total

1.  Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis.

Authors:  A Zimmermann; B Pöllinger; J Rieber; A König; I Erhard; F Krötz; H-Y Sohn; R Kantlehner; W Haimerl; E Dühmke; M Leibig; K Theisen; V Klauss; T M Schiele
Journal:  Z Kardiol       Date:  2005-04

Review 2.  Drug eluting stents: are human and animal studies comparable?

Authors:  R Virmani; F D Kolodgie; A Farb; A Lafont
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.